CEVEC further strengthens organization to drive industrialization and commercialization of CAP(R) technologies
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene thera…
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene thera…
CEVEC stellt ihre Expertise zur Verfügung und vergibt Lizenz für die Produktion ausgewählter Wachstums- und Differenzier…
CEVEC Pharmaceuticals GmbH (CEVEC), an expert for the production of glyco-optimized biopharmaceuticals, today announced…
CEVEC Pharmaceuticals, a clinical stage pharmaceutical company focusing on the development of highly potent protein and…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
CEVEC Pharmaceuticals ("CEVEC"), the developer of the CAP® Technology, a novel human expression system derived from amni…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes, and Yuhan Cor…
CEVEC Pharmaceuticals, the developer of a novel, market-leading human protein expression system derived from amniocytes,…
CEVEC Pharmaceuticals, licensing its human CAP® Technology based expression system for proteins and vaccines, today anno…
CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amni…